Hop rho iso-alpha acids, berberine, vitamin D3 and vitamin K1 favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial

Journal of Bone and Mineral Metabolism

Volumn 28, Issue 3, 2010, Pages 342-350

  Holick, Michael F ^a   Lamb, Joseph J ^b   Lerman, Robert H ^b   Konda, Veera R ^b   Darland, Gary ^b   Minich, Deanna M ^b   Desai, Anuradha ^b   Chen, Tai C ^a   Austin, Melissa ^b   Kornberg, Jacob ^b   Chang, Jyh Lurn ^b   Hsi, Alex ^b   Bland, Jeffrey S ^b   Tripp, Matthew L ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Metagenics Inc   (United States)

Author keywords

Bone turnover; Humulus lupulus; Kinase modulation; OC; Postmenopausal women

Indexed keywords

25 HYDROXYVITAMIN D; BERBERINE; COLECALCIFEROL; HUMULUS LUPULUS EXTRACT; OSTEOCALCIN; PHYTOMENADIONE; PLACEBO; RHO ISO ALPHA ACID; SOMATOMEDIN C; UNCLASSIFIED DRUG; 25 HYDROXYERGOCALCIFEROL; BIOLOGICAL MARKER; BONE DENSITY CONSERVATION AGENT; CALCIFEDIOL; PLANT EXTRACT;

ADULT; AEROBIC EXERCISE; ARTICLE; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MEDITERRANEAN DIET; NORMAL HUMAN; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT DURATION; VITAMIN BLOOD LEVEL; BLOOD; BONE REMODELING; CHEMISTRY; DIET SUPPLEMENTATION; HUMULUS; MIDDLE AGED; PHYTOTHERAPY; PILOT STUDY; POSTMENOPAUSE OSTEOPOROSIS; URINE;

25-HYDROXYVITAMIN D 2; BERBERINE; BIOLOGICAL MARKERS; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; CALCIFEDIOL; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HUMULUS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PHYTOTHERAPY; PILOT PROJECTS; PLANT EXTRACTS; POSTMENOPAUSE; SINGLE-BLIND METHOD; VITAMIN K 1;

EID: 77956042807     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-009-0141-z     Document Type: Article

References (45)

1. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR (1986) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319:516-518
2. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJ, Mundy GR (1989) Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125:1142-1150
3. Gowen M, Wood DD, Ihrie EJ, McGuire MK, Russell RG (1983) An interleukin 1 like factor stimulates bone resorption in vitro. Nature 306:378-380 (Pubitemid 14242749)
4. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T et al (1990) IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297-3303
5. Wells G, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P (2008) Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev CD004523
6. Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P (2008) Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev CD001155
7. Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P (2008) Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev CD003376
8. Lamb JJ (2006) Osteoporosis. In: Kohlstadt I (ed) scientific evidence for musculoskeletal, bariatric, and sports nutrition. CRC Press, Boca Raton, pp 473-490
9. Lanham-New SA (2008) Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment. Proc Nutr Soc 67:163-176
10. Cashman KD (2007) Diet, nutrition, and bone health. J Nutr 137:2507S-2512S
11. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ (1992) Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327:1637-1642
12. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J et al (2006) Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354:669-683 (Pubitemid 43247138)
13. Tucker KL, Chen H, Hannan MT, Cupples LA, Wilson PW, Felson D, Kiel DP (2002) Bone mineral density and dietary patterns in older adults: the Framingham Osteoporosis Study. Am J Clin Nutr 76:245-252
14. Prynne CJ, Mishra GD, O'Connell MA, Muniz G, Laskey MA, Yan L, Prentice A, Ginty F (2006) Fruit and vegetable intakes and bone mineral status: a cross sectional study in 5 age and sex cohorts. Am J Clin Nutr 83:1420-1428
15. Xu L, Dibley M, D'Este C, Phillips M, Porteous J, Attia J (2009) Food groups and risk of forearm fractures in postmenopausal women in Chengdu, China. Climacteric 12:222-229
16. Rosato MT, Schneider SH, Shapses SA (1998) Bone turnover and insulin-like growth factor I levels increase after improved glycemic control in noninsulin-dependent diabetes mellitus. Calcif Tissue Int 63:107-111
17. Cashman KD (2008) Altered bone metabolism in inflammatory disease: role for nutrition. Proc Nutr Soc 67:196-205
18. Konda VR, Desai A, Darland G, Bland JS, Tripp ML (2009) Rho iso-alpha acids from hops inhibit the GSK-3/NF-kappaB pathway and reduce inflammatory markers associated with bone and cartilage degradation. J Inflamm (Lond) 6:26
19. Hall AJ, Babish JG, Darland GK, Carroll BJ, Konda VR, Lerman RH, Bland JS, Tripp ML (2008) Safety, efficacy and antiinflammatory activity of rho iso-alpha-acids from hops. Phytochemistry 69:1534-1547
20. Tripp M, Konda VR, Hall A, Desai A, Carroll B, Darland G, Lerman R, Emma D, Bland JS (2006) Rho iso-alpha acids, a modified hop (Humulus lupulus) extract, inhibits protein kinases involved in autoimmune disease. FASEB J. 20:A1125
21. Kuo CL, Chi CW, Liu TY (2004) The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 203:127-137
22. Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC, Ho TY (2007) Berberine suppresses inflammatory agents-induced interleukin- 1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells. Pharmacol Res 56:193-201
23. Qin L, Han T, Zhang Q, Cao D, Nian H, Rahman K, Zheng H (2008) Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formula. J Ethnopharmacol 118:271-279
24. Giustina A,MazziottiG,Canalis E (2008)Growth hormone, insulinlike growth factors, and the skeleton. Endocr Rev 29:535-559
25. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T (2007) Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Osteoporos Int 18:1675-1681
26. Lerman RH, Minich DM, Darland G, Lamb JJ, Schiltz B, Babish JG, Bland JS, Tripp ML (2008) Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial. Nutr Metab (Lond) 5:29
27. White MA, Whisenhunt BL, Williamson DA, Greenway FL, Netemeyer RG (2002) Development and validation of the foodcraving inventory. Obes Res 10:107-114
28. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473-483
29. Greene JG (1998) Constructing a standard climacteric scale. Maturitas 29:25-31
30. Vasikaran SD (2008) Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis. Crit Rev Clin Lab Sci 45:221-258
31. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266-281
32. Cheng S, Suominen H, Vaananen K, Kakonen SM, Pettersson K, Heikkinen E (2002) Serum osteocalcin in relation to calcaneal bone mineral density in elderly men and women: a 5-year followup. J Bone Miner Metab 20:49-56
33. Nabipour I, Larijani B, Jafari SM, Amiri M, Amiri Z (2008) Reference database of CrossLaps and osteocalcin for a healthy Iranian population. Arch Iran Med 11:203-206
34. Ravn P, Rix M, Andreassen H, Clemmesen B, Bidstrup M, Gunnes M (1997) High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women. Calcif Tissue Int 60:255-260
35. Hu JP, Nishishita K, Sakai E, Yoshida H, Kato Y, Tsukuba T, Okamoto K (2008) Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways. Eur J Pharmacol 580:70-79
36. Wei P, Jiao L, Qin LP, Yan F, Han T, Zhang QY (2009) Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells. Zhong Xi Yi Jie He Xue Bao 7:342-348
37. Sakuma M, Endo N, Oinuma T (2007) Serum 25-OHD insufficiency as a risk factor for hip fracture. J Bone Miner Metab 25:147-150
38. Tsugawa N, Shiraki M, Suhara Y, Kamao M, Ozaki R, Tanaka K, Okano T (2008) Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J Bone Miner Metab 26:79-85
39. Kostek MC, Delmonico MJ, Reichel JB, Roth SM, Douglass L, Ferrell RE, Hurley BF (2005) Muscle strength response to strength training is influenced by insulin-like growth factor 1 genotype in older adults. J Appl Physiol 98:2147-2154
40. DiGirolamo DJ, Mukherjee A, Fulzele K, Gan Y, Cao X, Frank SJ, Clemens TL (2007) Mode of growth hormone action in osteoblasts. J Biol Chem 282:31666-31674
41. Yakar S, Kim H, Zhao H, Toyoshima Y, Pennisi P, Gavrilova O, Leroith D (2005) The growth hormone-insulin like growth factor axis revisited: lessons from IGF-1 and IGF-1 receptor gene targeting. Pediatr Nephrol 20:251-254
42. Melmed S, Jameson JL (2008) Disorders of the anterior pituitary and hypothalamus. In Fauci AS et al (eds) Harrison's principles of internal medicine, chap. 333, McGraw-Hill Professional, New York
43. Seibel MJ (2005) Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev 26:97-122
44. Nimptsch K, Hailer S, Rohrmann S, Gedrich K, Wolfram G, Linseisen J (2007) Determinants and correlates of serum undercarboxylated osteocalcin. Ann Nutr Metab 51:563-570
45. Karl PI, Friedman PA (1983) Effects of parathyroid hormone and vitamin D on the renal vitamin K-dependent carboxylating system. J Biol Chem 258:12783-12786